A review of metformin and its place in the diabetes guidelines
Metformin is considered to be the initial drug of choice for type 2 diabetes mellitus, particularly in overweight patients. This is based on its effectiveness in achieving glycaemic control, its favourable effects on weight, its low risk of causing hypoglycaemia and its reasonable cost. More importa...
Saved in:
| Main Author: | Gail Mkele |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2013-12-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/3964 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compliance of medical practitioners with diabetic treatment guidelines in West Rand, Gauteng
by: Nneka J. Ohanson, et al.
Published: (2023-03-01) -
Metformin and cancer mortality
by: Lev Mikhaylovich Bershteyn
Published: (2010-09-01) -
Gallic acid improves the metformin effects on diabetic kidney disease in mice
by: Yan Hong, et al.
Published: (2023-12-01) -
Antidiabetic potential of Gynura procumbens (Lour.) Merr.: a review of in vitro and in vivo studies
by: Nurul Hafizah Mohd Nor, et al.
Published: (2025-08-01) -
Allergic rhinitis in South Africa: 2012 guidelines
by: R.J. Green, et al.
Published: (2013-04-01)